| CKD | Chronic Kidney Disease |
| CI | Cognitive impairment |
| eGFR | Estimated glomerular filtration rate |
| BBB | Blood–Brain barrier |
| TMAO | Trimethylamine-N-oxide |
| NMDA | N-methyl-D-aspartate |
| ESRD | End-stage renal disease |
| MMSE | Mini-Mental State Examination |
| MoCA | Montreal Cognitive Assessment |
| NfL | Neurofilament light chain |
| NSE | Neuron-specific enolase |
| GFAP | Glial fibrillary acidic protein |
| BDNF | Brain-derived neurotrophic factor |
| JAM-1 | Junctional adhesion molecule-1 |
| IAA | Indole-3-acetic acid |
| CASI | Cognitive Abilities Screening Instrument |
| MCI | Mild cognitive impairment |
| MRI | Magnetic resonance imaging |